A congressman said on Wednesday that he intends to help bring the psychedelics reform movement to Capitol Hill “this year.” ​​​​​​​

Canadian singer and former teen idol Justin Bieber has partnered with Los Angeles-based cannabis company Palms to release “Peaches,” a product line of cannabis pre-rolls named after a song on his latest album, according to a Forbes report.

Despite the legalization of recreational marijuana in Illinois and problems with a new patient tracking system, the number of patients signed up for medical cannabis grew by 30% in the past year, while their cited reasons for doing so continue to evolve.

Optimi Health files a provisional patent application for a stable extraction method for natural psilocybin.

Levitee Labs reports (unaudited) revenues of CAD$893,863 for the month of August from clinic operations.

PharmaTher initiates a Phase 2a clinical trial for a ketamine-based therapy for Parkinson’s Disease, expected to commence in October 2021.

The Schedule I classification for psychedelic drugs needs to be changed. But to what — and when? Psychedelic Stock Watch takes a broad look at that question.

Voters in more than a dozen Ohio municipalities will decide on ballot measures to decriminalize marijuana next month.

Two billion people suffer from treatable mental health disorders resulting in 8 million preventable deaths per year. Psychedelics can address this catastrophe — but first these drugs must be legalized.

Yet another Michigan city has approved a resolution on Tuesday calling for decriminalization of a wide range of psychedelics such as psilocybin and ayahuasca.